Cargando…

Insights adjusting for non-adherence in randomized clinical trials: a reanalysis of an adjuvant trial of tamoxifen duration in early breast cancer

BACKGROUND: Several randomized clinical trials provide evidence of the survival benefit of extended adjuvant tamoxifen in women with estrogen receptor (ER)-positive early breast cancer (BC). However, non-adherence may lead to underestimate treatment effects using intention to treat (ITT) methods. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giudici, Fabiola, Pistilli, Barbara, Vaz-Luis, Ines, Karimi, Maryam, Delaloge, Suzette, Bachelot, Thomas, Michiels, Stefan, Bardet, Aurelie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628101/ https://www.ncbi.nlm.nih.gov/pubmed/37697030 http://dx.doi.org/10.1038/s41416-023-02420-w

Ejemplares similares

Association of Adherence to Endocrine Therapy Among Patients With Breast Cancer and Potential Drug-Drug Interactions
por: Rassy, Elie, et al.
Publicado: (2022)

Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk
por: Pistilli, Barbara, et al.
Publicado: (2020)

Adherence to Adjuvant Tamoxifen in Mexican Young Women with Breast Cancer
por: Martinez-Cannon, Bertha Alejandra, et al.
Publicado: (2021)

Adherence to adjuvant tamoxifen and associated factors in breast cancer survivors
por: Uslu, Yasemin, et al.
Publicado: (2023)

The Christie hospital adjuvant tamoxifen trial--status at 10 years.
por: Ribeiro, G., et al.
Publicado: (1988)

Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation.
Publicado: (1988)

Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. CRC Adjuvant Breast Trial Working Party.
Publicado: (1988)

Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances
por: Alper, Brian Scott, et al.
Publicado: (2020)

Statistical Methods in Recent HIV Noninferiority Trials: Reanalysis of 11 Trials
por: Flandre, Philippe
Publicado: (2011)

Adjuvant tamoxifen for early breast cancer.
por: Smith, I.
Publicado: (1988)

Tamoxifen resistance and adjuvant hormone therapy
por: Howell, A
Publicado: (2005)

Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer
por: Carbonnier, Vincent, et al.
Publicado: (2023)

The Italian Tamoxifen Prevention Trial
por: Bonanni, B., et al.
Publicado: (1999)

Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study
por: van Nes, J. G. H., et al.
Publicado: (2012)

Tamoxifen with ovarian function suppression versus tamoxifen alone as an adjuvant treatment for premenopausal breast cancer: a meta-analysis of published randomized controlled trials
por: Yan, Shunchao, et al.
Publicado: (2015)

Dynamics of Long-Term Patient-Reported Quality of Life and Health Behaviors After Adjuvant Breast Cancer Chemotherapy
por: Di Meglio, Antonio, et al.
Publicado: (2022)

Meta-analysis of trials comparing anastrozole and tamoxifen for adjuvant treatment of postmenopausal women with early breast cancer
por: Aydiner, Adnan, et al.
Publicado: (2008)

A controlled trial of adjuvant tamoxifen, with or without prednisolone, in post-menopausal women with operable breast cancer.
por: Fentiman, I. S., et al.
Publicado: (1994)

Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trial
por: Rosell, J, et al.
Publicado: (2011)

Adjuvant tamoxifen for male breast cancer (MBC).
por: Ribeiro, G., et al.
Publicado: (1992)

Rethinking remdesivir for COVID-19: A Bayesian reanalysis of trial findings
por: Hoek, Joyce M., et al.
Publicado: (2021)

Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630
por: Potkul, Ronald K, et al.
Publicado: (2016)

Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program
por: Le Du, Fanny, et al.
Publicado: (2023)

Target trial emulation to assess real-world efficacy in the Epidemiological Strategy and Medical Economics metastatic breast cancer cohort
por: Antoine, Alison, et al.
Publicado: (2023)

Endobronchial valves for emphysema: an individual patient-level reanalysis of randomised controlled trials
por: Klooster, Karin, et al.
Publicado: (2017)

Comparison of Treatment for Metabolic Disorders Associated with Autism:Reanalysis of Three Clinical Trials
por: Delhey, Leanna M., et al.
Publicado: (2018)

Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials
por: Woodhouse, Lisa J., et al.
Publicado: (2021)

Reanalysis of the Effect of Vitamin C on Mortality in the CITRIS-ALI Trial: Important Findings Dismissed in the Trial Report
por: Hemilä, Harri, et al.
Publicado: (2020)

Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up
por: Veron, Lucie, et al.
Publicado: (2021)

Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the ‘Arimidex™ and Tamoxifen Alone or in Combination’ (ATAC) trial
por: Trialists' Group, The ATAC
Publicado: (2001)

Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis
por: Kahan, Brennan C, et al.
Publicado: (2012)

Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project
por: Ezzalfani, Monia, et al.
Publicado: (2021)

Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group.
por: Stewart, H. J., et al.
Publicado: (1996)

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
por: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Publicado: (2011)

Safety and efficacy profile of pembrolizumab in solid cancer: pooled reanalysis based on randomized controlled trials
por: Wang, Manni, et al.
Publicado: (2017)

Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial
por: Jenkins, David J. A., et al.
Publicado: (2018)

Doxylamine-pyridoxine for nausea and vomiting of pregnancy randomized placebo controlled trial: Prespecified analyses and reanalysis
por: Persaud, Navindra, et al.
Publicado: (2018)

Safety and efficacy profile of Trastuzumab deruxtecan in solid cancer: pooled reanalysis based on clinical trials
por: Xu, Hanyue, et al.
Publicado: (2022)

Reanalysis of the Mars500 experiment reveals common gut microbiome alterations in astronauts induced by long-duration confinement
por: Brereton, N.J.B., et al.
Publicado: (2021)

Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen alone or in combination) trial
por: Mansel, R, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_5c9fd7b6c0e8prkn34dpte0v83